Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results

The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. In a press release issued September 24, PhaseBio Pharmaceuticals Inc. (PHAS...
Streetwise Reports | September 26, 2019 |

Sustained Silver Rally Coming?

Silver is still in consolidation mode since early September, but it appears ready to rally over a sustained period of time. Below, is a chart of silver: On the chart there appears to have formed some fractals. The current one has also broken out at the black line recentl...
Hubert Moolman | February 21, 2020 |

Gold Bull Outlines Australian Approach to Advance Sandman

As tight capital markets force Canadian explorers to get creative with fundraising, Gold Bull Resources Corporation (TSXV:GBRC, OTC:GBRCF) has unveiled plans to look inward for sustained explorati...
Research | October 7, 2022 |

Natural Gas Price Fundamental Daily Forecast – EIA Storage Report Expected to Show 91 Bcf Pull

The EIA will report on weekly storage at 15:30 GMT. The report is expected to show a drawdown of 91 Bcf for the week-ending January 10. James Hyerczyk Natural gas futures are edging higher shortly before the...
FX Empire | January 16, 2020 |

THE BIG D

According to Investopedia (even though the National Bureau of Economics has redefined it), “a recession is a macroeconomic term that refers to a significant decline in general economic activity in a designated region. It had been typically recognized as two consecutive quart...
Dr. Kal Kotecha | May 20, 2020 |

Prospera Energy corporate update: 3 years of strategic restructuring, recovery and future growth

CALGARY, Alberta, Oct. 24, 2024 (GLOBE NEWSWIRE) — Prospera Energy Inc. (“PEI”) (TSX.V: PEI, OTC: GXRFF, FRA: OF6B) The 2024 Prospera corporate update outlines the company’s restructuring efforts since 2021, highlighting key m...
Research | October 25, 2024 |

Buzz on the Bullboards: Healthcare Falls, Cannabis and Energy Rise

“What goes up must come down.” Over the past few months, many of the most-viewed and best-performing companies on the Stockhouse Bullboards have been in healthcare. Now, some of those companies are seeing excitement wane and share prices fall. A...
Omri Wallach | June 10, 2020 |

Buzz on the Bullboards: Early Movers in Health, Mining and Tech

By the second week of the year, people, businesses and even the stock market are back to business as usual following the holiday rush in December and ringing in the new year in early January. Discussions on our Stockhouse Bullboards are also back in the saddle, and co...
Stockhouse Editorial | January 12, 2022 |

Allakos Shares Double on AK002 Phase 2 Results and Earnings

Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. Clinical stage biotech company Allak...
Streetwise Reports | August 7, 2019 |

Avadel Shares Rise and Shine on Positive Phase 3 Narcolepsy Study Findings

Avadel Pharmaceuticals' shares traded 25% higher reaching a new 52-week high price after the company reported positive topline results from its Pivotal Phase 3 REST-ON trial of FT218 for the treatment of excessive daytime sleepiness and cataplexy in narcolepsy patients. ...
Streetwise Reports | April 28, 2020 |
1 2 3 4 5 6 7 8 9 10 ...